10 Best Medical Stocks to Buy Under $30
On April 28, Reuters reported that the US Food and Drug Administration has introduced a new pilot program that would allow the agency to monitor clinical trial data in real time.
Roivant Sciences Ltd. (ROIV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | QVT Financial Daniel Gold | 26,387,021 | $572,598,356 | -11% | 49.1% |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 10,677,894 | $231,710,300 | +48% | 0.35% |
| 3. | Two Seas Capital Sina Toussi | 9,791,891 | $212,484,035 | -17% | 4.38% |
| 4. | Rubric Capital Management David Rosen | 9,000,000 | $195,300,000 | -56% | 2.34% |
| 5. | Perceptive Advisors Joseph Edelman | 7,985,461 | $173,284,504 | +9% | 3.09% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.07 | 3,315 | $49,957.05 | 17,287,081 | 2025-09-18 | Filing | |
| $5.00 | 4,000,000 | $20,000,000.00 | 102,849,443 | 2022-11-10 | Filing | |
| $3.91 | 8,600 | $33,635.46 | 98,849,443 | 2022-04-25 | Filing | |
| $3.83 | 31,685 | $121,318.70 | 98,840,843 | 2022-04-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.59 | 200,000 | $5,918,000.00 | 1,647,546 | 2026-04-20 | Filing | |
| $29.16 | 289,774 | $8,449,809.84 | 16,736,116 | 2026-04-16 | Filing | |
| $28.37 | 13,538 | $384,073.06 | 84,191 | 2026-04-08 | Filing | |
| $27.45 | 70,000 | $1,921,500.00 | 42,963 | 2026-03-26 | Filing | |
| $28.24 | 200,000 | $5,648,000.00 | 1,647,546 | 2026-03-17 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,076,488 | $196,018,718 | 0.3% | |
| 2. | 2,673,233 | $74,048,554 | 0.08% | |
| 3. | 2,001,976 | $55,454,735 | 0.29% | |
| 4. | 1,955,046 | $54,154,775 | 0.01% | |
| 5. | 1,592,623 | $44,115,657 | 4.32% |
News See All
15 Under-the-Radar Picks from David Einhorn That Are Quietly Dominating 2026
David Einhorn, the founder and president of Greenlight Capital, is widely regarded as one of the most intellectually rigorous and disciplined value investors of his generation.
Billionaire Joe Edelman's 10 Stock Picks with Huge Upside Potential
Joseph Edelman, the billionaire chief of New York-based Perceptive Advisors, specializes in the biotechnology and life sciences sectors.
10 Must-Buy US Stocks to Buy Right Now
For some time, investors worried that the geopolitical conflict in the Middle East might drag on. That concern eased, at least temporarily, after U.S.
12 Best UK Stocks to Buy According to Hedge Funds
UK equities have spent much of the past decade trading at a discount to US peers, often overlooked in favor of faster-growing U.S. markets.
Citi Raises Roivant Sciences (ROIV) PT to $35 Following Positive Phase 2 Brepocitinib Data
Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the most promising low-cost stocks to buy now.
11 Most Promising Low-Cost Stocks to Buy Now
On February 7, Richard Bernstein, CEO of Richard Bernstein Advisors, joined 'The Exchange' on CNBC to discuss the state of equity markets, assessing which stocks are growing fast and trading cheaply.
TD Cowen Remains Bullish on Roivant Sciences Ltd. (ROIV) - Here's Why
Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best healthcare stocks under $50 to invest in. TD Cowen maintained a bullish outlook on Roivant Sciences Ltd.
12 Best Healthcare Stocks Under $50 to Invest In
On January 27, Jared Holz, healthcare equity strategist at Mizuho, appeared on CNBC’s 'Power Lunch' to talk about healthcare stocks and the new proposals around Medicare Advantage.
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Roivant Third Quarter 2025 Earnings Conference Call.